Sato R, Goldstein J L, Brown M S
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235-9046.
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9261-5. doi: 10.1073/pnas.90.20.9261.
An AMP-activated protein kinase has been reported to phosphorylate rodent 3-hydroxy-3-methylglutaryl-coenzyme A reductase [HMG-CoA reductase; (S)-mevalonate:-NAD+ oxidoreductase (CoA-acylating), EC 1.1.1.88] at Ser-871, thereby lowering its catalytic activity [Clarke, P. R. & Hardie, D. G. (1990) EMBO J. 9, 2439-2446]. To explore the physiologic role of this reaction, we prepared a cDNA encoding a mutant form of hamster HMG-CoA reductase with alanine substituted for serine at residue 871. When overexpressed in transfected cells, the wild-type enzyme, but not the Ser-871 to Ala mutant, was labeled with [32P]phosphate, confirming Ser-871 as the site of phosphorylation. The wild-type enzyme, but not the mutant enzyme, showed reduced activity when the cells were harvested with the phosphatase inhibitor KF, confirming phosphorylation as a mechanism for inactivation within the cell. Despite the lack of phosphorylation, the posttranscriptional feedback regulation of the mutant enzyme was normal, as indicated by reduced activity when cells were incubated with mevalonate, 25-hydroxycholesterol, or low density lipoprotein. Moreover, the mutant enzyme showed a normal acceleration of degradation when the transfected cells were incubated with sterols. Cells expressing the wild-type enzyme showed a decreased incorporation of [14C]pyruvate into sterols when ATP was depleted by incubation with 2-deoxy-D-glucose. No such reduction was seen in cells expressing the Ser-871 to Ala mutant enzyme. We conclude that the AMP-activated protein kinase does not play a role in end-product feedback regulation of HMG-CoA reductase, but rather it comes into play when cellular ATP levels are depleted, thereby lowering the rate of cholesterol synthesis and preserving the energy stores of the cell.
据报道,一种AMP激活的蛋白激酶可使啮齿动物的3-羟基-3-甲基戊二酰辅酶A还原酶[HMG-CoA还原酶;(S)-甲羟戊酸:-NAD+氧化还原酶(辅酶A酰化),EC 1.1.1.88]的丝氨酸871位点发生磷酸化,从而降低其催化活性[克拉克,P.R.和哈迪,D.G.(1990年)《欧洲分子生物学组织杂志》9,2439-2446]。为了探究该反应的生理作用,我们制备了一个编码仓鼠HMG-CoA还原酶突变体形式的cDNA,其中丝氨酸871位点被丙氨酸取代。当在转染细胞中过表达时,野生型酶而非丝氨酸871突变为丙氨酸的突变体被[32P]磷酸盐标记,证实丝氨酸871为磷酸化位点。当用磷酸酶抑制剂KF收获细胞时,野生型酶而非突变型酶的活性降低,证实磷酸化是细胞内失活的一种机制。尽管缺乏磷酸化,但突变型酶的转录后反馈调节正常,当细胞与甲羟戊酸、25-羟基胆固醇或低密度脂蛋白一起孵育时,其活性降低即表明了这一点。此外,当转染细胞与固醇一起孵育时,突变型酶显示出正常的降解加速。当用2-脱氧-D-葡萄糖孵育使ATP耗尽时,表达野生型酶的细胞中[14C]丙酮酸掺入固醇的量减少。在表达丝氨酸871突变为丙氨酸的突变型酶的细胞中未观察到这种减少。我们得出结论,AMP激活的蛋白激酶在HMG-CoA还原酶的终产物反馈调节中不起作用,而是在细胞ATP水平耗尽时发挥作用,从而降低胆固醇合成速率并保存细胞的能量储备。